BHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-05), Bausch Health's current share price is $6.20. Bausch Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $3.84. Bausch Health's Cyclically Adjusted Price-to-FCF for today is 1.61.
The historical rank and industry rank for Bausch Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, Bausch Health's highest Cyclically Adjusted Price-to-FCF was 118.91. The lowest was 1.07. And the median was 6.77.
BHC's Cyclically Adjusted Price-to-FCF is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Bausch Health's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.349. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.84 for the trailing ten years ended in Mar. 2024.
The historical data trend for Bausch Health's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | 2.12 | 2.04 | 2.13 | 2.02 | 2.77 |
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Bausch Health's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Bausch Health's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 6.20 | / | 3.84 | |
= | 1.61 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Bausch Health's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.349 | / | 126.2576 | * | 126.2576 | |
= | 0.349 |
Current CPI (Mar. 2024) = 126.2576.
Bausch Health Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201406 | 0.739 | 99.473 | 0.938 |
201409 | 1.479 | 99.394 | 1.879 |
201412 | 1.987 | 98.367 | 2.550 |
201503 | 1.096 | 99.789 | 1.387 |
201506 | 1.029 | 100.500 | 1.293 |
201509 | 1.952 | 100.421 | 2.454 |
201512 | 1.481 | 99.947 | 1.871 |
201603 | 1.415 | 101.054 | 1.768 |
201606 | 1.099 | 102.002 | 1.360 |
201609 | 1.371 | 101.765 | 1.701 |
201612 | 1.287 | 101.449 | 1.602 |
201703 | 2.240 | 102.634 | 2.756 |
201706 | 0.631 | 103.029 | 0.773 |
201709 | 1.255 | 103.345 | 1.533 |
201712 | 1.433 | 103.345 | 1.751 |
201803 | 1.115 | 105.004 | 1.341 |
201806 | 0.373 | 105.557 | 0.446 |
201809 | 1.391 | 105.636 | 1.663 |
201812 | 0.725 | 105.399 | 0.868 |
201903 | 1.042 | 106.979 | 1.230 |
201906 | 0.784 | 107.690 | 0.919 |
201909 | 1.226 | 107.611 | 1.438 |
201912 | 0.422 | 107.769 | 0.494 |
202003 | 0.535 | 107.927 | 0.626 |
202006 | 0.363 | 108.401 | 0.423 |
202009 | 0.486 | 108.164 | 0.567 |
202012 | 0.871 | 108.559 | 1.013 |
202103 | 1.051 | 110.298 | 1.203 |
202106 | 1.102 | 111.720 | 1.245 |
202109 | 1.549 | 112.905 | 1.732 |
202112 | 0.067 | 113.774 | 0.074 |
202203 | -0.333 | 117.646 | -0.357 |
202206 | 0.185 | 120.806 | 0.193 |
202209 | -3.638 | 120.648 | -3.807 |
202212 | 1.045 | 120.964 | 1.091 |
202303 | 0.284 | 122.702 | 0.292 |
202306 | 0.477 | 124.203 | 0.485 |
202309 | 0.646 | 125.230 | 0.651 |
202312 | 0.672 | 125.072 | 0.678 |
202403 | 0.349 | 126.258 | 0.349 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Seana Carson | officer: EVP, General Counsel | 400 SOMERSET CORPORATE BLVD, BRIDGEWATER NJ 08807 |
John S Barresi | officer: SVP, Controller & CAO | 727 FIFTH AVENUE, NEW YORK NY 10022 |
Richard Mulligan | director | C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153 |
Tom George Vadaketh | officer: EVP, Chief Financial Officer | 1727 JOCKEYS WAY, YARDLEY PA 19067 |
Robert Spurr | director, officer: U.S. President-Pharma Business | C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Joseph F Gordon | officer: Pres&Co-Head Bausch&Lomb/Int'l | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Frederick Munsch | officer: SVP, Controller and CAO | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Christina Ackermann | officer: EVP AND GENERAL COUNSEL | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Sam Eldessouky | officer: EVP & Chief Financial Officer | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Steven D Miller | director | 16690 COLLINS AVENUE, PH, SUNNY ISLE BEACH FL 33160 |
Von Eschenbach Andrew C. | director | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
De Schutter Richard U | director | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Brett Icahn | director | C/O ICAHN ENTERPRISES L.P., 16690 COLLINS AVE., PH, SUNNY ISLES FL 33160 |
William D. Humphries | officer: EVP, COMPANY GROUP CHAIRMAN | C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044 |
Valueact Capital Master Fund, L.p. | director, other: See remarks | ONE LETTERMAN DRIVE, BUILDING D, 4TH FLOOR, SAN FRANCISCO CA 94129 |
From GuruFocus
By ACCESSWIRE • 01-18-2024
By PRNewswire • 09-21-2023
By PRNewswire • 09-21-2023
By ACCESSWIRE • 12-18-2023
By ACCESSWIRE • 10-10-2023
By PRNewswire • 09-21-2023
By ACCESSWIRE • 11-01-2023
By Business Wire • 09-22-2023
By ACCESSWIRE • 09-21-2023